Monitoring Accrual by Gender, Race and Ethnicity

The Program for the Elimination of Cancer Disparities (PECaD) at the Siteman Cancer Center works with the cancer center's Protocol Review and Monitoring Committee (PRMC) to evaluate accrual of minority patients in the institution’s clinical studies and to help investigators achieve appropriate representation by gender, race and ethnicity.

When submitting protocols for review to the PRMC, all investigators are required to identify target patient accrual by gender, race and ethnicity. Appropriate study accrual targets should reflect the population being studied and may take into account population-specific risk factors.

Treatment and ancillary studies: Investigators are advised to use the "Incidence Cancer Cases by Disease Site" table (link below).

Prevention and screening studies: Investigators are advised to use the population data for the primary catchment area in the "Demographic Information" chart (link below).

For studies specifically looking at cancer issues for minority populations, investigators may want to set higher accrual targets than the percentages listed in these two tables.

For more information or questions about the tables, please Jennifer Tappenden at tappendenj@wudosis.wustl.edu.